Areteia Therapeutics, Inc. — Form D/A
Areteia Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D amendment with the SEC on 2025-02-21. The offering totals $445.0M, of which $360.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-21
- Form: D/A
- Accession: 0001937542-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $445.0M
- Amount sold: $360.0M
- Remaining: $85.0M
- Investors: 16
- Date of first sale: 2022-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-452352
Issuer
- Name: Areteia Therapeutics, Inc.
- CIK: 0001937542
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 101 GLEN LENNOX DR., CHAPEL HILL, NC, 27517
- Phone: 617-504-0362
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Jorge E Bartolome | Director | Chapel Hill, NC |
| Daniel E Becker | Director | Chapel Hill, NC |
| Paul Berns | Director | AUSTIN, TX |
| Michael E Bozik | Director | Chapel Hill, NC |
| Stephen E Butts | Director | Morrisville, NC |
| Benjamin Gomez | Director | Chapel Hill, NC |
| Adam Koppel | Director | Boston, MA |
| Ian Read | Director | Round Rock, TX |
| Elyse E Stock | Director | Chapel Hill, NC |
| Jorge E Bartolome | Executive Officer | Chapel Hill, NC |
| Christopher E Courts | Executive Officer | Chapel Hill, NC |
| Robin E Walker | Executive Officer | Chapel Hill, NC |
| Chris E Visioli | Executive Officer | Short Hills, NJ |
| Christopher Todd Cox | Executive Officer | Short Hills, NJ |
| Whit E Bernard | Executive Officer | Short Hills, NJ |
Other filings by this issuer (2)
More